Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R. Vogl TJ, et al. Among authors: kummel s. Radiology. 1996 Jul;200(1):59-67. doi: 10.1148/radiology.200.1.8657946. Radiology. 1996. PMID: 8657946 Clinical Trial.
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R. Vogl TJ, et al. Among authors: kummel s. Invest Radiol. 1996 Nov;31(11):696-708. doi: 10.1097/00004424-199611000-00004. Invest Radiol. 1996. PMID: 8915751 Clinical Trial.
Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
Hammerstingl R, Vogl TJ, Schwarz W, Kümmel S, Balzer T, Neuhaus P, Felix R. Hammerstingl R, et al. Among authors: kummel s. Acad Radiol. 1998 Apr;5 Suppl 1:S75-9; discussion S93-4. doi: 10.1016/s1076-6332(98)80066-4. Acad Radiol. 1998. PMID: 9561049 Clinical Trial. No abstract available.
Primary Open Versus Closed Implantation Strategy for Totally Implantable Venous Access Ports: The Multicentre Randomized Controlled PORTAS-3 Trial (DRKS 00004900).
Hüttner FJ, Bruckner T, Hackbusch M, Weitz J, Bork U, Kotschenreuther P, Heupel O, Kümmel S, Schlitt HJ, Mattulat M, Pintér L, Seiler CM, Gutt CN, Nottberg HS, Pohl A, Ghanem F, Meyer T, Imdahl A, Neudecker J, Müller VA, Gehrig T, Reineke M, von Frankenberg M, Schumacher G, Hennes R, Mihaljevic AL, Rossion I, Klose C, Kieser M, Büchler MW, Diener MK, Knebel P. Hüttner FJ, et al. Among authors: kummel s. Ann Surg. 2020 Dec;272(6):950-960. doi: 10.1097/SLA.0000000000003705. Ann Surg. 2020. PMID: 31800490 Clinical Trial.
Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors.
Watanabe M, Fendler WP, Grafe H, Hirmas N, Hamacher R, Lanzafame H, Pabst KM, Hautzel H, Aigner C, Kasper S, von Tresckow B, Stuschke M, Kümmel S, Lugnier C, Hadaschik B, Grünwald V, Zarrad F, Siveke JT, Herrmann K, Weber M. Watanabe M, et al. Among authors: kummel s. J Nucl Med. 2024 May 23:jnumed.123.266981. doi: 10.2967/jnumed.123.266981. Online ahead of print. J Nucl Med. 2024. PMID: 38782454
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.
Dent R, André F, Gonçalves A, Martin M, Schmid P, Schütz F, Kümmel S, Swain SM, Bilici A, Loirat D, Villalobos Valencia R, Im SA, Park YH, De Laurentis M, Colleoni M, Guarneri V, Bianchini G, Li H, Kirchmayer Machackova Z, Mouta J, Deurloo R, Gan X, Fan M, Mani A, Swat A, Cortés J. Dent R, et al. Among authors: kummel s. Ann Oncol. 2024 May 7:S0923-7534(24)00107-8. doi: 10.1016/j.annonc.2024.04.001. Online ahead of print. Ann Oncol. 2024. PMID: 38755096 Free article.
307 results